Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

@article{Lerch2017CurrentPO,
  title={Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis},
  author={M Lerch and Carlo Mainetti and Benedetta Terziroli Beretta-Piccoli and Thomas Harr},
  journal={Clinical Reviews in Allergy \& Immunology},
  year={2017},
  volume={54},
  pages={147-176}
}
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are considered a delayed-type hypersensitivity reaction to drugs. They represent true medical emergencies and an early recognition and appropriate management is decisive for the survival. SJS/TEN manifest with an “influenza-like” prodromal phase (malaise, fever), followed by painful cutaneous and mucous membrane (ocular, oral, and genital) lesions, and other systemic symptoms. The difference between SJS, SJS/TEN overlap, and… 
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis
TLDR
Recent advances in the pathophysiology and management ofStevens-Johnson syndrome and toxic epidermal necrolysis are discussed.
Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum for the rheumatologist
TLDR
A patient with SJS/TEN as a presenting feature poses two-fold challenge to a rheumatologist as it could be a manifestation of lupus or side effects of a myriad of drugs used by the rhearatologist.
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Twin Sisters after Ibuprofen Administration. New Insights in Pathogenesis and Literature Review
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are closely-related, severe, acute life-threatening, drug-induced skin and mucosal disorders with a high mortality rate or
Oseltamivir induced Stevens–Johnson syndrome/toxic epidermal necrolysis—case report
TLDR
A 9-year-old girl with upper respiratory tract infections presented with generalized maculopapular rash the second day after taking oseltamivir, which is a very rare event and is reported to attract attention to the rare but serious side effect of this antiviral drug.
Stevens–Johnson Syndrome: A Challenging Diagnosis
TLDR
A 17-year-old female who presented to her primary care provider with a chief complaint of headache was initially diagnosed with a urinary tract infection and prescribed nitrofurantoin, and over the next 2 days, her symptoms worsened, she presented to the emergency department twice, and was transferred to a burn unit for definitive care.
Fatal pediatric Stevens–Johnson syndrome/toxic epidermal necrolysis
TLDR
Establish a clinically predictive score that includes severe infection for pediatric patients to evaluate the risk of mortality in children in order to improve poor outcomes.
Management of Severe Skin Eruptions
TLDR
In this chapter, the diagnosis and management of SJS/TEN will be discussed and the conflicting data on systemic therapy is addressed.
A Case of Toxic Epidermal Necrolysis Caused by the Use of Trimethoprim Alone
TLDR
This report presents a 54-year-old man who developed a widespread erythematous rash soon after the use of trimethoprim for an episode of acute prostatitis and made a steady recovery supported by the wider multidisciplinary team.
Toxic epidermal necrosis associated with phenobarbitone: a case report and brief review of the literatures
TLDR
A 14-year-old asthmatic male patient admitted to a local hospital for an acute exacerbation of asthma and developed toxic epidermal necrosis following exposure to Phenobarbitone is described, highlighting the better prognosis observed in pediatric population with TEN.
Risk Factors for Mortality in Senile Patients with Toxic Epidermal Necrolysis in Taiwan
First described by Lyell in 1956, toxic epidermal necrolysis (TEN) is a rare disease and has an annual incidence of about 1–5 cases per million population. Although there is a clear understanding of
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 271 REFERENCES
Stevens–Johnson syndrome and toxic epidermal necrolysis in children
TLDR
Evaluation of children with SJS/TEN, investigation of causative drug/drugs, treatment, clinical outcome, and complications are presented in three cases.
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update
TLDR
This review summarizes up-to-date insights on SJS/TEN and describes a protocol for assessment and treatment, and it is hoped these suggested guidelines serve as a practical clinical tool in the management of SJS /TEN.
[Stevens-Johnson syndrome and toxic epidermal necrolysis in children].
TLDR
In children there are no uniform criteria for classification of the skin lesions, neither for the treatment, however recently the authors describe better response of the patients with use intravenous immunoglobulin (IGIV).
Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.
TLDR
The mortality rate in this study was lower than that in previous reports and the use of systemic steroids was higher in the survival group in comparison with the non-survival group (65.1 vs. 0%, respectively; P=0.014).
Causative Drugs of Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis in Israel
TLDR
Accumulating evidence suggests that the risk may be greater with high doses and rapid dose escalation, at least for allopurinol and lamotrigine, and that the variability among ethnic groups may also apply to Israeli populations.
Long-term Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
TLDR
Visceral organ involvement was observed in 2 patients with irreversible deterioration of chronic kidney disease and in one patient with interstitial lung disease, and the 2 most common sequelae were cutaneous and ocular problems, both with incidences of 44.1%.
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.
TLDR
A large and longitudinal observational study on the epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in a European and largely white study population observes statistically significant associations between SJS/TEN and pre-existing depression, lupus erythematosus, recent pneumonia, chronic kidney disease, and active cancer.
Urogynecologic complications in Stevens-Johnson syndrome and toxic epidermal necrolysis: Presentation of a case and recommendations for management
TLDR
Skin biopsy found vacuolar alteration and necrotic keratinocytes along the dermal-epidermal junction and sparse lymphocytic infiltrate, confirming the suspected diagnosis of toxic epidermal necrolysis (TEN).
Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study.
TLDR
The use of the TEN-specific severity-of-illness score (SCORTEN) was validated and several prognostic indicators were identified, most significant being HIV-tuberculosis co-infection, ≥40% skin involvement and severe sepsis.
Stevens-Johnson syndrome and toxic epidermal necrolysis in childhood-onset systemic lupus erythematosus patients: a multicenter study.
TLDR
This study identified Stevens-Johnson syndrome and overlap SJS-TEN as rare manifestations of active cSLE associated with severe multisystemic disease, with potentially lethal outcome.
...
1
2
3
4
5
...